Sildenafil Citrate Medicine Description And Treatments
There are several conditions that can be treated with Sildenafil. Here are some of them: Infertility, Inflammatory Bowel Disease, Pulmonary arterial hypertension, and Sexual dysfunction.
Read on to learn more. This article will also cover some of the possible side effects of Sildenafil. You should consult a healthcare professional before using this medicine. Read the manufacturer’s information leaflet to learn more.
The medical community has not approved sildenafil citrate as a medical treatment for infertility. The infertility Cenforce 100mg drug is also not covered by some health plans.
Most of them exclude it as an out-of-pocket expense. However, Aetna considers this medicine to be medically necessary for its members. For example, it covers follitropins injections for infertility.
The study involved 80 women who suffered from infertility but were otherwise healthy. The subjects were evaluated for aPL positivity on day 21 of their menstrual cycle.
Plasma samples were tested using an enzyme-linked immunosorbent assay (ELISA). The study authors used SPSS version 16.0 to conduct statistical analysis. The results were consistent with other studies. If you have an aPL positive test, you may have a high risk for infertility.
Inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic, progressive inflammatory disorder that can lead to various complications, such as ulcers, bleeding, and constipation.
Treatments for IBD include reducing inflammation to minimize the symptoms and the risk of complications. Treatments for IBD may include corticosteroids and anti-inflammatories, such as aminosalicylates, mesalamine, and balsalazine.
Inflammatory bowel disease is a condition that affects the intestines and is most common in developing countries. Although the disease has an international prevalence of 0.3%, the epidemiology of the condition has changed over the past few decades, particularly in newly industrialized countries.
In China, for example, the morbidity of IBD was 1.74 per 100,000 person-years. In developed countries, the disease is still a serious, global health issue that burdens both individuals and families.
Pulmonary arterial hypertension
The effects of sildenafil on pulmonary artery pressure were evaluate using several measures. These included vasodilation, arterial stiffness, wave reflection, and aortic pressure.
Therefore, pulmonary arterial hypertension with sildenafil may be beneficial for a range of patients.
Efficacy and safety of sildenafil were assesse in a 12-week prospective study in patients with COPD and pulmonary arterial hypertension. Patients were randomize to receive 20 mg of sildenafil or a placebo over a 12-week period.
At baseline, all patients had received standard COPD therapy. Echocardiography was performe for diagnosis and monitoring of cardiovascular disease. Patients’ baseline walking distance was also measure four to six weeks after the study.
Another study showed that sildenafil reduced right ventricular mass. They also observed reduced expression of matrix metalloproteinases and decreased volume of right ventricular mass.
The findings of this study suggest that sildenafil may have antiproliferative effects on smooth muscle cells, which is important for the treatment of pulmonary arterial hypertension. The results suggest that sildenafil is an effective treatment for pulmonary arterial hypertension.
Sildenafil Citrate Cenforce 25 mg is a drug approved by the FDA to treat erectile dysfunction in men. It works by inhibiting phosphodiesterase type 5, a key enzyme in the penile arteries that causes cyclic guanosine 3-monophosphate to degrade.
This in turn causes an increase in blood flow to the penis, causing an erection. Although most people experience erections when sexually stimulated, they may not always be a result of ED. The usual dosage is 50 to 100 mg daily, and there are several brands and strengths available for men to choose from.
The study was conducte with a randomized, controlled trial design, and a randomize, double-blind design. In addition, patients were stratified according to age, race, body mass index, duration of ED, smoking status, and concomitant conditions.
The patient population was well-balance between sildenafil and placebo groups. The outcomes of these trials varied from 41.3% to 46.7%, depending on the severity of the sexual dysfunction.